The WACC of Healthlynked Corp (HLYK) is 6.6%.
Range | Selected | |
Cost of equity | 5.4% - 8.3% | 6.85% |
Tax rate | 26.2% - 27.0% | 26.6% |
Cost of debt | 4.0% - 7.0% | 5.5% |
WACC | 5.2% - 8.0% | 6.6% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.33 | 0.61 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 5.4% | 8.3% |
Tax rate | 26.2% | 27.0% |
Debt/Equity ratio | 0.1 | 0.1 |
Cost of debt | 4.0% | 7.0% |
After-tax WACC | 5.2% | 8.0% |
Selected WACC | 6.6% | |
Debt/Equity | Unlevered | |||
Peers | Company Name | ratio | Beta | beta |
HLYK | Healthlynked Corp | 0.1 | 1.95 | 1.82 |
APYI | Aspyra Inc | 0.53 | 0.2 | 0.14 |
CMPD | CompuMed Inc | 0.05 | 0.33 | 0.32 |
KSI.V | Kneat.com Inc | 0.04 | 0.51 | 0.5 |
MITI | Mitesco Inc | 0.43 | -1.06 | -0.81 |
MLKNA | MedLink International Inc | 0.45 | 1.22 | 0.92 |
NHEL | Natural Health Farm Holdings Inc | 0.09 | 1.27 | 1.19 |
RHT.V | Reliq Health Technologies Inc | 0.01 | 0.99 | 0.98 |
WORX | Scworx Corp | 0.04 | 2.04 | 1.98 |
ALMDT.PA | Median Technologies SA | 0.44 | -0.45 | -0.34 |
Low | High | |
Unlevered beta | 0.43 | 0.94 |
Relevered beta | 0 | 0.42 |
Adjusted relevered beta | 0.33 | 0.61 |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for HLYK:
cost_of_equity (6.85%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.33) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.